...
机译:脑脊液导流后淀粉样蛋白β1-42毒致β1-42的变化预测特发性正常压力脑积水患者的长期认知结果
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurol Bunkyo Ku Tokyo Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Kyoto Prefectural Univ Med Dept Neurol Kamigyo Ku Kyoto Japan;
Kyoto Univ Grad Sch Agr Div Food Sci &
Biotechnol Sakyo Ku Kyoto Japan;
Juntendo Univ Dept Neurosurg Bunkyo Ku 2-1-1 Hongo Tokyo 1138421 Japan;
Alzheimer's disease; amyloid-beta 1-42; amyloid clearance; cerebrospinal-fluid shunting; cognitive function; idiopathic normal pressure hydrocephalus; oligomer; phosphorylated tau; toxic conformer;
机译:脑脊液导流后淀粉样蛋白β1-42毒致β1-42的变化预测特发性正常压力脑积水患者的长期认知结果
机译:脑脊液生物标志物,用于特发性正常压力脑积水患者的长期认知治疗结果预后
机译:脑脊液生物标志物用于特发性正常压力脑积水患者长期认知治疗的预后
机译:特发性正常压力脑积分分流后手术结果的神经心理预测因子
机译:脑脊液转移后淀粉样蛋白β1-42毒性构象比的变化预测了特发性正常压力性脑积水患者的长期认知结果
机译:脑脊液生物标志物用于特发性正常压力脑积水患者长期认知治疗的预后